Protease Inhibitor Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Protease Inhibitor stocks.

Protease Inhibitor Stocks Recent News

Date Stock Title
May 9 BCRX BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
May 9 BCRX Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results
May 7 BCRX BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
May 7 BCRX BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
May 7 BCRX BioCryst: Estimate-Beating Q1 But Risks Are Considerable
May 7 BCRX BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
May 7 BCRX Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
May 6 BCRX Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
May 6 BCRX BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
May 6 BCRX BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
May 6 BCRX BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2024 Earnings Call Transcript
May 6 BCRX BioCryst surges 18% on quarterly earnings, adjusted guidance outlook
May 6 BCRX BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 6 BCRX BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts
May 6 BCRX BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
May 6 BCRX BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook
May 6 BCRX BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
May 3 BCRX BioCryst Pharmaceuticals Q1 2024 Earnings Preview
Protease Inhibitor

Protease inhibitors are drugs that block the activity of proteases, enzymes that break down proteins. They are used to treat HIV and other viral infections, as well as some types of cancer. Protease inhibitors work by binding to the active site of the protease enzyme, preventing it from breaking down proteins. This can stop the virus from replicating and reduce the amount of virus in the body.

Browse All Tags